Apyx Medical Corp Finance Lease, Right-of-Use Asset, Amortization
Apyx Medical Corp (APYX) reported Finance Lease, Right-of-Use Asset, Amortization of $21.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-03-10
- Apyx Medical Corp finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $53.00K.
- Apyx Medical Corp finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $4.00K.
- Apyx Medical Corp finance lease, right-of-use asset, amortization for fiscal 2025 was $21.00K, a 0.00% change from fiscal 2024.
- Apyx Medical Corp finance lease, right-of-use asset, amortization for fiscal 2024 was $21.00K, a 32.26% decline from fiscal 2023.
- Apyx Medical Corp finance lease, right-of-use asset, amortization for fiscal 2023 was $31.00K, a 77.54% decline from fiscal 2022.
- Apyx Medical Corp finance lease, right-of-use asset, amortization for fiscal 2022 was $138.00K, a 36.11% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $21.00K 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $21.00K 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $31.00K 10-K · filed 2025-03-13 | |||
| 2022-12-31 | $138.00K 10-K · filed 2024-03-21 | |||
| 2021-12-31 | $216.00K 10-K · filed 2023-03-16 | |||
| 2020-12-31 | $216.00K 10-K · filed 2022-03-17 | |||
| 2019-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $57.00K derived: sum of 2 quarters · filed 2021-03-31 | $57.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $4.00K 10-Q · filed 2019-11-15 | $4.00K 10-Q · filed 2019-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |